As of 2025-06-07, the Fair Value of Medipharm Labs Corp (LABS.TO) is -0.09 CAD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.08 CAD, the upside of Medipharm Labs Corp is -212.46%.
With the market price of 0.08 CAD and our fair value calculation, Medipharm Labs Corp (LABS.TO) is not a good investment. Investing in LABS.TO stocks now will result in a potential loss of 212.46%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -66.40 | -54.80 | -30.00 | -13.08 | -10.69 | -35.00 |
| YoY growth | -4,250.00% | 17.47% | 45.26% | 56.39% | 18.26% | -822.52% |
| Market Cap (mil) | 33.21 |
| P/E | |
| Forward P/E |
| EPS | -0.02 |
| Avg earnings growth rate | -822.52% |
| TTM earnings | -7.47 |